Adamas Pharmaceuticals Appoints Neil McFarlane as Chief Executive Officer
Gregory Went, Ph.D., Founder, transitions to a strategic advisory role – David Mahoney, lead independent director, appointed to Chairman of the Board …
Name: Gregory Went
Continent: North America
Country: USA
Company: Adamas Pharmaceuticals, Inc.
Position: CEO & Chairman
Reason: Resigned
Replaced By: Neil McFarlane
Announcement Date: September 12, 2019, 10:00pm
Resignation Date: